Australia markets closed

Neurogene Inc. (NGNE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.31-0.41 (-1.22%)
At close: 04:00PM EDT
33.31 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
47,652
44,394
47,505
42,264
Selling general and administrative
13,675
11,189
9,012
8,270
Total operating expenses
61,327
55,583
56,517
50,534
Operating income or loss
-61,327
-55,583
-56,517
-50,534
Interest expense
13
12
2
0
Total other income/expenses net
15,871
16,327
-7
-
Income before tax
-40,975
-36,317
-55,189
-50,517
Income from continuing operations
-40,975
-36,317
-55,189
-50,517
Net income
-40,975
-36,317
-55,189
-50,517
Net income available to common shareholders
-40,975
-36,317
-55,189
-50,517
Basic EPS
-33.51
-73.83
-37.80
-34.60
Diluted EPS
-33.51
-73.83
-37.80
-34.60
Basic average shares
1,460
491.867
1,460
1,460
Diluted average shares
1,460
4,657
1,460
1,460